Palvella Therapeutics, Inc Earnings

The next earnings date for Palvella Therapeutics, Inc has not yet been scheduled.

Analyst Estimates of Palvella Therapeutics, Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Palvella Therapeutics, Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/29/2024	---	$-2.19	---
08/01/2024	---	$-2.76	---
05/08/2024	---	$-3.95	---
03/27/2024	---	$-3.71	---
11/08/2023	---	$-8.70	---
08/03/2023	---	$3.62	---
05/10/2023	---	$-14.15	---
03/29/2023	---	$-8.70	---
11/02/2022	---	$-10.47	---
08/04/2022	---	$-11.16	---
05/11/2022	---	$-5.54	---
03/01/2022	---	$-10.56	---
11/02/2021	---	$-19.53	---
08/04/2021	---	$-20.03	---
05/17/2021	---	$-5.93	---
03/30/2021	---	$-20.57	---
11/04/2020	---	$-21.03	---
08/10/2020	---	$-7.56	---
05/11/2020	---	$-5.21	---
03/12/2020	---	$-5.22	---
11/11/2019	---	$-4.20	---
08/07/2019	---	$-19.12	---
05/08/2019	---	$-16.27	---
03/20/2019	---	$-17.26	---
11/07/2018	---	$-9.10	---
08/09/2018	---	$-0.30	---
05/10/2018	---	$-13.93	---
03/09/2018	---	$13.31	---
11/09/2017	---	$-12.72	---
08/10/2017	---	$-18.59	---
05/11/2017	---	$-14.85	---
03/23/2017	---	$-12.19	---
11/10/2016	---	$-11.51	---
08/10/2016	---	$-11.52	---
05/12/2016	---	$-8.36	---
03/23/2016	---	$-5.83	---
11/12/2015	---	$-8.07	---
08/13/2015	---	$-9.60	---
06/03/2015	---	$-7.32	---

More About Palvella Therapeutics, Inc

Website

https://palvellatx.com

Country

USA

Full Time Employees

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania

“Palvella Therapeutics, Inc Earnings” Can Refer to the Palvella Therapeutics, Inc Earnings Date

Some people say “Palvella Therapeutics, Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Palvella Therapeutics, Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Palvella Therapeutics, Inc Stock on the Earnings Date

If you own Palvella Therapeutics, Inc stock (PVLA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Palvella Therapeutics, Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Palvella Therapeutics, Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Palvella Therapeutics, Inc Earnings

You can contact us any time if you would like to ask questions about Palvella Therapeutics, Inc earnings or anything else related to the stock market.